PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Root extracts showed antimicrobial activity against Shigella dysenteriae, Vibrio cholerae, and H. pylori [PMID:9292414, PMID:22465506]. Leaf extracts showed activity against Neisseria gonorrhoeae [PMID:12480115].
Ethanolic stem bark extract significantly suppressed Plasmodium berghei infection in mice (55.17% to 71.10% depending on dose) [PMID:37435530].
The ethyl acetate fraction of the leaf showed antipsychotic-like effects in ketamine-induced psychosis in mice [PMID:33842914].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 9292414 (1997) — Antimicrobial activity of Terminalia macroptera root. · Journal of ethnopharmacology
- 2.PMID: 22465506 (2012) — Anti-Helicobacter pylori activity of Terminalia macroptera root. · Fitoterapia
- 3.PMID: 33842914 (2021) — Antipsychotic-like effect of ethyl acetate fraction of Terminalia macroptera leaf in mice. · IBRO neuroscience reports
- 4.PMID: 25017373 (2014) — Enzyme inhibition, antioxidant and immunomodulatory activities, and brine shrimp toxicity of extracts from the root bark, stem bark and leaves of Terminalia macroptera. · Journal of ethnopharmacology
- 5.PMID: 37435530 (2023) — Antimalarial and Antioxidant Activities of Ethanolic Stem Bark Extract of Terminalia macroptera in Swiss Albino Mice Infected with Plasmodium berghei.